The goal of this activity is to provide up-to-date information and multiple perspectives on the evolving pathogenesis, symptoms, risk factors, and complications of T2DM as well as current and emerging treatments and best practices in the management of patients with T2DM.

Dr. Henry continues his discussion by giving an overview of classes of pharmacologic therapies, and their effects on different blood lipids. He also reviews key recommendations from guidelines regarding the treatment of dyslipidemia, reviews key clinical trials, and provides up-to-date information on recent and ongoing trials.

Part 2. Therapy for Dyslipidemia in Type 2 Diabetes Mellitus

In this segment, Robert Henry, MD, discusses risk factors related to blood lipids, predictors of risk beyond LDL-C, recommendations for lipid levels, and customizing goals for therapy, in patients with type 2 diabetes.